Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for hairy cell leukemia

Leukemia and Lymphoma

Volumn 39, Issue 5-6, 2000, Pages 657-659

  Sarmiento, M A ^a   Neme, D ^a   Fornari, M C ^a   Bengio R M ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

2 CDA; 2 chlorodeoxyadenosine; Guillain Barr syndrome; Hairy cell leukemia

Indexed keywords

CLADRIBINE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1B; GANGLIOTETRAOSYLCERAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; VIRUS ANTIBODY;

AGED; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CULTURE; CASE REPORT; FEBRILE NEUTROPENIA; GUILLAIN BARRE SYNDROME; HAIRY CELL LEUKEMIA; HUMAN; INFECTION; MALE; NEUROTOXICITY; PERIPHERAL NERVE; PRIORITY JOURNAL; SCREENING; URINE CULTURE;

EID: 0034485315     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009113398     Document Type: Article

References (6)

1. 2Chlorodeoxyadenosine dose escalation in non hematologic malignancies
2. Neurotoxicity of purine analogs: A review
3. The relationship between plasma 2-Chloro-2′deoxyadenosine (CdA) and cellular CdA nucleotides (CdAN) after intermittent and continuous i.v. infusion in patients with chronic lymphocytic leukemia
4. Effect of high doses of 2-CdA on Schwann cells of mouse peripheral nerve
5. Antibodies to gangliosides in Guillain-Barré syndrome: Specifity and relationship to clinical features
6. Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides